ClinicalTrialsFinder

Anaplastic Lymphoma Kinase I1171N Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting

A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

Carcinoma, Non-Small Cell LungAnaplastic Lymphoma Kinase I1171NEnsartinib
Peking Union Medical College Hospital490 enrolled1 locationNCT05498064